AKTIENANLEIHE - EVOTEC Share Price

Certificat

DE000VU9ZFN8

Market Closed - Deutsche Boerse AG 11:34:39 17/05/2024 pm IST
40.02 EUR -4.12% Intraday chart for AKTIENANLEIHE - EVOTEC
Current month-1.77%
1 month-27.90%
Date Price Change
17/24/17 40.02 -4.12%
16/24/16 41.74 -3.07%
15/24/15 43.06 +2.50%
14/24/14 42.01 +2.86%
13/24/13 40.84 +3.79%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 11:34 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying EVOTEC SE
IssuerLogo Issuer Vontobel Vontobel
WKN VU9ZFN
ISINDE000VU9ZFN8
Date issued 18/07/2023
Strike 26
Maturity 21/06/2024 (35 Days)
Parity 0.03 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 105.4
Lowest since issue 39.15

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9.76 EUR
Average target price
21.99 EUR
Spread / Average Target
+125.31%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW